Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum

R. K. Rao, Y. Lopez, P. J M Riviere, X. Pascaud, J. L. Junien, Frank Porreca

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The possible involvement of nitric oxide in the regulation of intestinal ion transport induced by neuropeptide Y (NPY) was investigated by evaluating the effects of N(G)-methyl-L-arginine (L-NMA), L-arginine and S-nitroso-N - acetylpenicillamine (SNAP) on NPY activity in mouse ileum mounted in Ussing chambers in vitro. Serosal NPY (10 nM) produced a sustained decrease in basal transmural short circuit current (I(sc)) and potential difference without altering the tissue conductance. Pretreatment of tissues with L-arginine (3 mM), but not o-arginine (10 mM), blocked the NPY-mediated changes in I(sc). This L-arginine effect on NPY activity was reversed by L-NMA (3 mM), and not by N(G)-methyl-D-arginine (10 mM). The L-arginine effect on NPY activity was concentration-related with an A50 (95% CL) value of 1.6 (0.9-2.3) mM. In contrast to L-arginine, L-NMA (1 mM) pretreatment of tissues produced an enhancement of NPY activity, resulting in a 3.8-fold leftward displacement of the NPY concentration-response curve; N(G)-methyl-D-arginine was with out effect. The effect of L-NMA on NPY activity was concentration-related with an A50 (95% CL) value of 45.3 (23.2-68.8) μM. Serosal application of SNAP, a nitric oxide donor, produced a concentration-related decrease in basal I(sc) and potential difference without altering tissue conductance with an A50 (95% CL) value of 22.5 (11.1-40.5) μM. Pretreatment of tissue with SNAP (100 μM) reduced the NPY activity with rightward displacement of NPY concentration-response curve. Pretreatment of tissues with L-arginine also blocked the reduction of I(sc) by [D-Pen2,D-Pen5]enkephalin (10-30 nM), H2N-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 (10-30 nM) and somatostatin (0.3-1.0 μM), but had no effect on norepinephrine (0.1-0.3 μM)-induced decrease in mouse ileal I(sc). These results show that [fgc]I-arginine and SNAP block NPY-mediated changes in ion transport, suggesting that nitric oxide may play a role in the regulation of NPY-mediated ion transport in the mouse ileum.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume278
Issue number1
StatePublished - Jul 1996

Fingerprint

Neuropeptide Y
Ion Transport
Ileum
Nitric Oxide
Arginine
S-Nitroso-N-Acetylpenicillamine
D-Penicillamine (2,5)-Enkephalin
Nitric Oxide Donors
Somatostatin
Norepinephrine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum. / Rao, R. K.; Lopez, Y.; Riviere, P. J M; Pascaud, X.; Junien, J. L.; Porreca, Frank.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 278, No. 1, 07.1996, p. 193-198.

Research output: Contribution to journalArticle

Rao, R. K. ; Lopez, Y. ; Riviere, P. J M ; Pascaud, X. ; Junien, J. L. ; Porreca, Frank. / Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum. In: Journal of Pharmacology and Experimental Therapeutics. 1996 ; Vol. 278, No. 1. pp. 193-198.
@article{75dba0760df5443da21e14e97d096806,
title = "Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum",
abstract = "The possible involvement of nitric oxide in the regulation of intestinal ion transport induced by neuropeptide Y (NPY) was investigated by evaluating the effects of N(G)-methyl-L-arginine (L-NMA), L-arginine and S-nitroso-N - acetylpenicillamine (SNAP) on NPY activity in mouse ileum mounted in Ussing chambers in vitro. Serosal NPY (10 nM) produced a sustained decrease in basal transmural short circuit current (I(sc)) and potential difference without altering the tissue conductance. Pretreatment of tissues with L-arginine (3 mM), but not o-arginine (10 mM), blocked the NPY-mediated changes in I(sc). This L-arginine effect on NPY activity was reversed by L-NMA (3 mM), and not by N(G)-methyl-D-arginine (10 mM). The L-arginine effect on NPY activity was concentration-related with an A50 (95{\%} CL) value of 1.6 (0.9-2.3) mM. In contrast to L-arginine, L-NMA (1 mM) pretreatment of tissues produced an enhancement of NPY activity, resulting in a 3.8-fold leftward displacement of the NPY concentration-response curve; N(G)-methyl-D-arginine was with out effect. The effect of L-NMA on NPY activity was concentration-related with an A50 (95{\%} CL) value of 45.3 (23.2-68.8) μM. Serosal application of SNAP, a nitric oxide donor, produced a concentration-related decrease in basal I(sc) and potential difference without altering tissue conductance with an A50 (95{\%} CL) value of 22.5 (11.1-40.5) μM. Pretreatment of tissue with SNAP (100 μM) reduced the NPY activity with rightward displacement of NPY concentration-response curve. Pretreatment of tissues with L-arginine also blocked the reduction of I(sc) by [D-Pen2,D-Pen5]enkephalin (10-30 nM), H2N-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 (10-30 nM) and somatostatin (0.3-1.0 μM), but had no effect on norepinephrine (0.1-0.3 μM)-induced decrease in mouse ileal I(sc). These results show that [fgc]I-arginine and SNAP block NPY-mediated changes in ion transport, suggesting that nitric oxide may play a role in the regulation of NPY-mediated ion transport in the mouse ileum.",
author = "Rao, {R. K.} and Y. Lopez and Riviere, {P. J M} and X. Pascaud and Junien, {J. L.} and Frank Porreca",
year = "1996",
month = "7",
language = "English (US)",
volume = "278",
pages = "193--198",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Nitric oxide modulates neuropeptide Y regulation of ion transport in mouse ileum

AU - Rao, R. K.

AU - Lopez, Y.

AU - Riviere, P. J M

AU - Pascaud, X.

AU - Junien, J. L.

AU - Porreca, Frank

PY - 1996/7

Y1 - 1996/7

N2 - The possible involvement of nitric oxide in the regulation of intestinal ion transport induced by neuropeptide Y (NPY) was investigated by evaluating the effects of N(G)-methyl-L-arginine (L-NMA), L-arginine and S-nitroso-N - acetylpenicillamine (SNAP) on NPY activity in mouse ileum mounted in Ussing chambers in vitro. Serosal NPY (10 nM) produced a sustained decrease in basal transmural short circuit current (I(sc)) and potential difference without altering the tissue conductance. Pretreatment of tissues with L-arginine (3 mM), but not o-arginine (10 mM), blocked the NPY-mediated changes in I(sc). This L-arginine effect on NPY activity was reversed by L-NMA (3 mM), and not by N(G)-methyl-D-arginine (10 mM). The L-arginine effect on NPY activity was concentration-related with an A50 (95% CL) value of 1.6 (0.9-2.3) mM. In contrast to L-arginine, L-NMA (1 mM) pretreatment of tissues produced an enhancement of NPY activity, resulting in a 3.8-fold leftward displacement of the NPY concentration-response curve; N(G)-methyl-D-arginine was with out effect. The effect of L-NMA on NPY activity was concentration-related with an A50 (95% CL) value of 45.3 (23.2-68.8) μM. Serosal application of SNAP, a nitric oxide donor, produced a concentration-related decrease in basal I(sc) and potential difference without altering tissue conductance with an A50 (95% CL) value of 22.5 (11.1-40.5) μM. Pretreatment of tissue with SNAP (100 μM) reduced the NPY activity with rightward displacement of NPY concentration-response curve. Pretreatment of tissues with L-arginine also blocked the reduction of I(sc) by [D-Pen2,D-Pen5]enkephalin (10-30 nM), H2N-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 (10-30 nM) and somatostatin (0.3-1.0 μM), but had no effect on norepinephrine (0.1-0.3 μM)-induced decrease in mouse ileal I(sc). These results show that [fgc]I-arginine and SNAP block NPY-mediated changes in ion transport, suggesting that nitric oxide may play a role in the regulation of NPY-mediated ion transport in the mouse ileum.

AB - The possible involvement of nitric oxide in the regulation of intestinal ion transport induced by neuropeptide Y (NPY) was investigated by evaluating the effects of N(G)-methyl-L-arginine (L-NMA), L-arginine and S-nitroso-N - acetylpenicillamine (SNAP) on NPY activity in mouse ileum mounted in Ussing chambers in vitro. Serosal NPY (10 nM) produced a sustained decrease in basal transmural short circuit current (I(sc)) and potential difference without altering the tissue conductance. Pretreatment of tissues with L-arginine (3 mM), but not o-arginine (10 mM), blocked the NPY-mediated changes in I(sc). This L-arginine effect on NPY activity was reversed by L-NMA (3 mM), and not by N(G)-methyl-D-arginine (10 mM). The L-arginine effect on NPY activity was concentration-related with an A50 (95% CL) value of 1.6 (0.9-2.3) mM. In contrast to L-arginine, L-NMA (1 mM) pretreatment of tissues produced an enhancement of NPY activity, resulting in a 3.8-fold leftward displacement of the NPY concentration-response curve; N(G)-methyl-D-arginine was with out effect. The effect of L-NMA on NPY activity was concentration-related with an A50 (95% CL) value of 45.3 (23.2-68.8) μM. Serosal application of SNAP, a nitric oxide donor, produced a concentration-related decrease in basal I(sc) and potential difference without altering tissue conductance with an A50 (95% CL) value of 22.5 (11.1-40.5) μM. Pretreatment of tissue with SNAP (100 μM) reduced the NPY activity with rightward displacement of NPY concentration-response curve. Pretreatment of tissues with L-arginine also blocked the reduction of I(sc) by [D-Pen2,D-Pen5]enkephalin (10-30 nM), H2N-Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 (10-30 nM) and somatostatin (0.3-1.0 μM), but had no effect on norepinephrine (0.1-0.3 μM)-induced decrease in mouse ileal I(sc). These results show that [fgc]I-arginine and SNAP block NPY-mediated changes in ion transport, suggesting that nitric oxide may play a role in the regulation of NPY-mediated ion transport in the mouse ileum.

UR - http://www.scopus.com/inward/record.url?scp=0030434271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030434271&partnerID=8YFLogxK

M3 - Article

VL - 278

SP - 193

EP - 198

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -